Lilienfeld D.E., Syrucek L., History of epidemiologic surveillance – W. Farr 1807–1883, „Cesk. Epidemiol. Mikrobiol, Imunol” 1972; 21: 321–324.

National Association of Chronic Disease Directors, Public Health Advances Through Chronic Disease Prevention: 1986–2006. Atlanta 2007.

National Center for Health Statistics (NCHS), www.cdc.gov/nchs/ (dostęp 30.11.2011).

CDC, Healthy Aging – Helping People to Live Long and Productive Lives and Enjoy a Good Quality of Life, At A Glance, Center Disease Control and Prevention, Atlanta 2011.

Eyles J., Birch S.A., A population needs-based approach to health care resource allocation and planning in Ontario: A link between policy goals and practice, „Can. J. Public Health” 1993; 84(2): 112–117.

CDC, Premature mortality in the United States: Public health issues in the use of years of potential life lost, „MMWR Morb. Mortal Wkly Rep.” 1986; 35(suppl 2): 1S–11S.

WHO, 10 facts on noncommunicable diseases, World Health Organization, Geneva 2011.

WHO, Though choices: Investing in Health for Development, World Health Organization, Geneva 2006.

WHO, The Global Burden of Disease, 2004 update, World Health Organization, Geneva 2008.

Hawkes C., Avoidable Chronic Diseases, European Health Forum, Gastein, October 2005.

Strong K. et al., Preventing chronic diseases, How many lives can we save? „The Lancet” 2005; 66(9496): 1578–1582.

WHO resolution 57–17, Global Strategy on Diet, Physical Activity and Health, World Health Organization, Geneva 2004.

Mathers C.D., Loncar D., Projections of global mortality and burden of disease from 2002 to 2030, PLoS Med 3, World Health Organization, Geneva 2006.

Jagger C. et al., Life Expectancy with Chronic Morbidity, Major and Chronic Diseases – report 2007, European Commission, Brussells 2009.

GUS, Stan Zdrowia Ludności Polski w 2004 roku, Główny Urząd Statystyczny, Warszawa 2006.

Zajenkowska-Kozłowska A., Piekarzewska M., Europejskie Ankietowe Badanie Zdrowia w 2009 r., Główny Urząd Statystyczny, Warszawa 2010

ADI, World Alzheimer Report 2009, Alzheimer Disease’s International, 2009.

Anderson G., Horvath J.,The Growing Burden of Chronic Disease in America, „Public Health Reports” 2004; 119, no. 3: 263–270.

Pliskin J.S., Shepard D.S., Weinstein M.C., Utility Functions for Life Years and Health Status, „Operations Research” 1980; 28: 206–224.

Thommasen H.V., Zhang W., Impact of chronic disease on quality of life in the Bella Coola Valley, „Rural and Remote Health” 2006; 6: 528.

Brown N., Melville M., Gray D., Young T., Munro J., Skene A., Hampton J., Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal population, „Heart” 1999; 81(4): 352–358.

Lima M.G., Barros M.B., César C.L., Goldbaum M., Carandina L., Ciconelli R.M., Impact of chronic disease on quality of life among the elderly in the state of São Paulo, Brazil: a population-based study, „Rev. Panam. Salud. Publica” 2009; 25(4): 314–321.

Jenkinson C. Stewart-Brown S., Petersen S., Paice C., Assessment of the SF-36 version 2 in the United Kingdom, „J. Epidemiol. Community Health” 1999; 53: 45–50.

Wood-Dauphinee S., The Canadian SF-36 health survey: Normative data add to its value, „CMAJ” 2000; vol. 163, 3: 283–284.

Murray C.J.L., Salomon J., Mathers C.D. et al., Summary Measures of Population Health: concepts, ethics, measurement and applications, World Health Organization, Geneva 2002.

Murray C.J.L., Lopez A.D., The Global Burden of Disease, Harvard University Press, Cambridge 1996.

WHO, Preventing Chronic Diseases – a vital investment, World Health Organization, Geneva 2005.

Suhrcke M., Urban D., Iburg K.M. et al., The economic benefits of health and prevention in a high-income country: the example of Germany, WHO European Office for Health and Development, Venice 2007.

Abegunde D., Stanciole A., An estimation of the economic impact of chronic noncommunicable diseases in selected countries, World Health Organization, Geneva 2006.

Suhrcke M., Nugent R.A., Stuckler D., Rocco L., Chronic disease: an economic perspective, Oxford Health Alliance, Oxford 2006.

Efroymson D. et al., Hungry for tobacco: an analysis of the economic impact of tobacco consumption on the poor in Bangladesh, „Tob Control” 2001; 10: 212–217.

Ernst M. et al., Smoking history and nicotine effects on cognitive performance, „Neuropsycho-pharmacology” 2001; 25: 313–319.

Hay J.W., The harm they do to others: a primer on the external costs of drug abuse, w: Krauss M.B, Lazear E.P. (red.), Searching for alternatives: drug-control policy in the United States, Hoover Institution Press, Stanford (CA) 1991, 200–225.

Rosamond W. et al., Heart Disease and Stroke Statistics – 2007 Update, „Circulation” 2007; 115: e69–e171.

Leal J. Luengo-Fernández R. et al., Economic burden of cardiovascular diseases in the enlarged European Union, „Eur. Heart J.” 2006; 27(13): 1610–1619.

American Diabetes Association, Economic Costs of Diabetes in the U.S. in 2002, „Diabetes Care” 2003; 236(3): 917–932.

Pronk N.P., Martinson B., Kessler R.C. et al.,The association between work performance and physical activity, cardiorespiratory fitness, and obesity, „J. Occup. Environ. Med.” 2004; 46: 19–25.

Ostbye T., Dement J.M., Krause K.M., Obesity and workers’ compensation: results from the Duke and Safety Surveillance System, „Arch. Intern. Med.” 2007; 167: 766–73.

OECD, The Prevention Of Lifestyle-Related Chronic Dis­eases: An Economic Framework, w: Sassi F., Hurst J. (red.), OECD Health Working Paper 2008, No. 32.

WHO, Preventing chronic diseases: a vital investment, World Health Organization, 2005.

Nugent R.,Chronic Diseases: A Growing Problem,„Diabetes Voice” 2008; 53: 17–20.

WHO, Global Health Risks, World Health Organization, Geneva 2009.

Pająk A., Zwalczanie choroby niedokrwiennej serca poprzez modyfikację czynników ryzyka, „Acta Angiol.” 1996; 2: 111–122.

Armstrong T., Prevention of Chronic Diseases, WHO Global Strategy on Diet Physical Activity and Health, Diabetes Summit Africa, 2007.

NHS, Our inheritance, our future: realising the potential of genetics in the National Health Service, London 2003.

Rappaport S.M., Smith M.T., Epidemiology. Environment and Disease Risks, „Science” 2010; 330(6003): 460–461.

Vineis P., A self-fulfilling prophecy: are we underestimating the role of the environment in gene – environment interaction research?, „International Journal of Epidemiology” 2004; 33: 945–946.

Willett W.C., Balancing Life-Style and Genomics Research for Disease Prevention, „Science” 2002; 296: 695.

Stedman’s Medical Dictionary, 28 Edition, 2006.

Doll R., Peto R., Boreham J., Sutherland I., Mortality in relation to smoking: 50 years’ observations on male British doctors, „BMJ” 2004; 328(7455): 1519.

WHO, The Tabacco Atlas, World Health Organization, Geneva 2002.

OHA, Three risk factors, Fact Pack, Oxford Health Alliance, Oxford 2007.

Uchwała Nr 90/2007 Rady Ministrów z dnia 15 maja 2007, Narodowy Program Zdrowia na lata 2007–2012, Załącznik do Uchwały, Warszawa 2007.